Search Results

Business

Calyptus Pharmaceuticals Announces Partnership with Provepharm to Accelerate Development of an Acute Care Injectable Product

Calyptus Pharmaceuticals, Inc., (“Calyptus”) announced that it entered into an agreement with Provepharm SAS (“Provepharm”), to accelerate the development, marketing and distribution of a complex injectable product used in acute care settings.

August 22, 2022

·

2 min read

FDA

Provepharm announces that it has received FDA approval for BLUDIGOTM (Indigotindisulfonate Sodium, USP) Injection.

Provepharm, a French company with operations in the United States of America, specializing in the development of pharmaceutical applications, today announced that it has received FDA New Drug Approval for the marketing of its injectable BLUDIGO™ (Indigotindisulfonate Sodium) Injection.

July 12, 2022

·

5 min read

Deals

Provepharm Life Solutions invests €9M in its new pilot production unit

Company inaugurates its new production unit for active pharmaceutical ingredients, the cornerstone of Provepharm’s development

September 29, 2019

·

2 min read

Pharm Country

American Regent Launches a New Vial Presentation

American Regent, Inc. and Provepharm Life Solutions are pleased to announce the availability of ProvayBlue® Injection, USP in a 10 mL single-dose vial.

June 30, 2022

·

11 min read

Provepharm Life Solutions wins the 2018 Prix Galien-MedStartUp Award

Provepharm Life Solutions and partner Walter Reed Army Institute of Research were selected for project focusing on anti-malaria treatment in endemic regions

November 12, 2018

·

4 min read

PROVEPHARM LIFE SOLUTIONS WINS THE 2018 PRIX GALIEN-MEDSTARTUP AWARD

Provepharm Life Solutions, a French independent pharmaceutical and life sciences group which revitalizes known molecules, announces today it has won the 2018 Prix Galien-Medstartup Award.

November 7, 2018

·

3 min read

Provepharm Life Solutions receives €42M

New funding will enable pharmaceutical group to accelerate program of international growth through acquisitions

May 9, 2019

·

2 min read

Provepharm’s Proveblue Methylene Blue Drug Substance Achieves Full Compliance With The Latest US And European Pharmacopoeial Standards

November 21, 2016

·

2 min read

FDA

Provepharm Receives FDA Approval For Marketing Of Provayblue (Methylene Blue) Injection

May 11, 2016

·

1 min read

Provepharm Launches Provedye®, Its First Medical Device, In Europe

January 27, 2015

·

2 min read